Insmed Incorporated Insmed Incorporated

Insmed Incorporated

INSM

Kedudukan dalam Saham #1107
Insmed Incorporated operates as a biopharmaceutical enterprise focused on... Insmed Incorporated operates as a biopharmaceutical enterprise focused on creating and introducing medical solutions for individuals facing severe and uncommon health conditions. The company's marketed treatment, ARIKAYCE, is administered to adult patients suffering from Mycobacterium avium complex (MAC) lung disease, serving as a component of a broader antibacterial drug regimen. In its development pipeline, Insmed is advancing Brensocatib, an oral and reversible inhibitor targeting dipeptidyl peptidase 1, which is being investigated for its potential in treating bronchiectasis and other disorders mediated by neutrophils. Additionally, the firm is developing Treprostinil Palmitil Inhalation Powder, an inhaled version of the treprostinil palmitil prodrug, designed to address pulmonary arterial hypertension and various other rare lung ailments. Founded in 1988, Insmed Incorporated maintains its primary corporate offices in Bridgewater, New Jersey.
Harga Saham
$95.65
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$20.89B
Perubahan (1 hari)
-0.65%
Perubahan (1 tahun)
-43.04%
Negara
US
Perdagangan Insmed Incorporated (INSM)

Kategori

Healthcare
Sejarah pecahan saham untuk Insmed Incorporated (INSM)
Saham Insmed Incorporated (simbol: INSM) telah mengalami sejumlah 2 pecahan saham.
Pecahan saham terkini berlaku pada Mar 03, 2011.
Satu saham INSM yang dibeli sebelum Jul 31, 2000 kini bersamaan dengan 0.025 saham INSM.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
2011-03-03 1:10 x0.1 x0.025
2000-07-31 1:4 x0.25 x0.25
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL